Kuroki K, Tada H
J Arrhythm. 2025; 41(1):e70011.
PMID: 39906095
PMC: 11792576.
DOI: 10.1002/joa3.70011.
Kingdon A, Adcock H, Kasimati E, Craven P, van Schaik W, Cox L
J Antibiot (Tokyo). 2024; 78(1):54-63.
PMID: 39402358
PMC: 11700842.
DOI: 10.1038/s41429-024-00781-9.
Mohammed A, Naveed M, Szabados T, Szatmari I, Lorinczi B, Matyus P
Sci Rep. 2024; 14(1):23188.
PMID: 39369049
PMC: 11455950.
DOI: 10.1038/s41598-024-73576-5.
Nagpal A, Pundkar A, Singh A, Gadkari C
Cureus. 2024; 16(8):e66549.
PMID: 39252710
PMC: 11381938.
DOI: 10.7759/cureus.66549.
Hu H, Wang L, Li H, Li H, Chen X, Peng W
Fundam Res. 2024; 2(6):829-835.
PMID: 38933375
PMC: 11197581.
DOI: 10.1016/j.fmre.2022.05.002.
Exosomal miRNA Changes Associated with Restoration to Sinus Rhythm in Atrial Fibrillation Patients.
Tsai P, Ko A, Chen Y, Chiu C, Yeh Y, Tsai F
Int J Mol Sci. 2024; 25(7).
PMID: 38612670
PMC: 11011649.
DOI: 10.3390/ijms25073861.
Cardiac arrhythmogenesis: roles of ion channels and their functional modification.
Lei M, Salvage S, Jackson A, Huang C
Front Physiol. 2024; 15:1342761.
PMID: 38505707
PMC: 10949183.
DOI: 10.3389/fphys.2024.1342761.
Wound incidence and outcomes in atrial fibrillation: Comparing catheter ablation and anti-arrhythmic drug therapy.
Xinyu Z, Sheng X
Int Wound J. 2023; 21(4):e14612.
PMID: 38130027
PMC: 10961873.
DOI: 10.1111/iwj.14612.
The Synergistic Relationship Between Atrial Fibrillation and Diabetes Mellitus: Implications for Cardiovascular and Metabolic Health.
Mohsin M, Zeyad H, Khalid H, Gapizov A, Bibi R, Kamani Y
Cureus. 2023; 15(9):e45881.
PMID: 37885547
PMC: 10599207.
DOI: 10.7759/cureus.45881.
Further Quinolizidine Derivatives as Antiarrhythmic Agents- 3.
Tasso B, Mattioli L, Tonelli M, Boido V, Chiarini A, Sparatore F
Molecules. 2023; 28(19).
PMID: 37836759
PMC: 10574513.
DOI: 10.3390/molecules28196916.
Multiplatform modeling of atrial fibrillation identifies phospholamban as a central regulator of cardiac rhythm.
Kervadec A, Kezos J, Ni H, Yu M, Marchant J, Spiering S
Dis Model Mech. 2023; 16(7).
PMID: 37293707
PMC: 10387351.
DOI: 10.1242/dmm.049962.
Vanoxerine kills mycobacteria through membrane depolarization and efflux inhibition.
Kingdon A, Meosa-John A, Batt S, Besra G
Front Microbiol. 2023; 14:1112491.
PMID: 36778873
PMC: 9909702.
DOI: 10.3389/fmicb.2023.1112491.
Novel Arylpiperazine Derivatives of Salicylamide with α-Adrenolytic Properties Showed Antiarrhythmic and Hypotensive Properties in Rats.
Zmudzka E, Lustyk K, Siwek A, Wolak M, Galuszka A, Jaskowska J
Int J Mol Sci. 2023; 24(1).
PMID: 36613736
PMC: 9820316.
DOI: 10.3390/ijms24010293.
Mechanisms and Management of Thyroid Disease and Atrial Fibrillation: Impact of Atrial Electrical Remodeling and Cardiac Fibrosis.
Takawale A, Aguilar M, Bouchrit Y, Hiram R
Cells. 2022; 11(24).
PMID: 36552815
PMC: 9777224.
DOI: 10.3390/cells11244047.
Blockade of SK4 channels suppresses atrial fibrillation by attenuating atrial fibrosis in canines with prolonged atrial pacing.
Wang Y, Yao Y, Ma Y, He S, Yang M, Cao Z
Int J Med Sci. 2022; 19(14):1995-2007.
PMID: 36483596
PMC: 9724246.
DOI: 10.7150/ijms.69626.
The Complex Relation between Atrial Cardiomyopathy and Thrombogenesis.
DAlessandro E, Winters J, van Nieuwenhoven F, Schotten U, Verheule S
Cells. 2022; 11(19).
PMID: 36230924
PMC: 9563762.
DOI: 10.3390/cells11192963.
Open channel block of Kv1.5 channels by HMQ1611.
Dong C, Li J, Ding W, Ueda R, Xie X, Wu J
Front Pharmacol. 2022; 13:965086.
PMID: 36188606
PMC: 9524145.
DOI: 10.3389/fphar.2022.965086.
Common Structural Pattern for Flecainide Binding in Atrial-Selective K1.5 and Na1.5 Channels: A Computational Approach.
Mazola Y, Marquez Montesinos J, Ramirez D, Zuniga L, Decher N, Ravens U
Pharmaceutics. 2022; 14(7).
PMID: 35890252
PMC: 9318806.
DOI: 10.3390/pharmaceutics14071356.
Human Atrial Cardiac Microtissues for Chamber-Specific Arrhythmic Risk Assessment.
Soepriatna A, Kim T, Daley M, Song E, Choi B, Coulombe K
Cell Mol Bioeng. 2021; 14(5):441-457.
PMID: 34777603
PMC: 8548481.
DOI: 10.1007/s12195-021-00703-x.
Translational Studies on Anti-Atrial Fibrillatory Action of Oseltamivir by its and Electropharmacological Analyses.
Kambayashi R, Izumi-Nakaseko H, Goto A, Tsurudome K, Ohshiro H, Izumi T
Front Pharmacol. 2021; 12:593021.
PMID: 33995006
PMC: 8118603.
DOI: 10.3389/fphar.2021.593021.